Article Information
History
- April 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cagla Akay-Espinoza1,
- Sarah Bond1,
- Beth A. Dombroski2,
- Asha Kallianpur3,4,
- Ajay Bharti5,
- Donald R. Franklin6,
- Gerard D. Schellenberg2,
- Robert K. Heaton6,
- Igor Grant6,
- Ronald J. Ellis6,7,
- Scott L. Letendre6,7 and
- Kelly L. Jordan-Sciutto1,*
- 1Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 2Department of Pathology and Laboratory Medicine, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
- 3Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA
- 4Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44195, USA
- 5Departments of Medicine, University of California, San Diego, CA, 92093, USA
- 6Psychiatry, University of California, San Diego, CA, 92093, USA
- 7Neurosciences, University of California, San Diego, CA, 92093, USA
- ↵*Corresponding author:
Kelly Jordan-Sciutto, Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, 240 S. 40th St, Rm 312 Levy, Philadelphia, PA 19104, Phone: 215-898-4196; E-mail: jordank{at}upenn.edu
Posted April 23, 2022.
Genetic variations in EIF2AK3 are associated with neurocognitive impairment in people living with HIV
